Add BrightSurf on Google Email

Scientists pinpoint new drug target for RSV

Scientists at Trinity College Dublin have identified a key biological pathway, the JAK/STAT pathway, that RSV suppresses and prevents immune system igniters from activating. This discovery provides a promising new target for therapeutic immune restoration and could lead to significant impact in treating RSV infections.

SourceTrinity College Dublin·JournalFrontiers in Immunology·DateJul 19, 2024

A kissing bug humans do not want to canoodle

Researchers identified a kissing bug in Delaware with the Chagas disease-causing parasite Trypanosoma cruzi. Entomologists confirmed the insect's presence and found it was infected with the parasite, which can lead to serious heart problems if left untreated.

SourceUniversity of Delaware·JournalAmerican Journal of Tropical Medicine and Hygiene·DateJun 26, 2024

Olympics: how many days does it take for mosquitoes in Greater Paris to transmit arboviruses, and what preventive measures are needed?

A study found that mosquitoes in Greater Paris can transmit five arboviruses within different time frames, with West Nile virus transmitted in as little as three days. The results highlight the importance of increased surveillance and control measures to prevent disease outbreaks during the Olympic Games.

SourceInstitut Pasteur·JournalEurosurveillance·TypeExperimental study·DateJun 24, 2024

Could auto-antibodies be linked to severe COVID-19?

Researchers found auto-antibodies against type I interferons in severe and critical COVID-19 patients, compromising their immune response. This discovery highlights the importance of detecting these auto-antibodies in regular health checkups to better prepare for viral infections.

SourceChiba University·JournalJournal of Clinical Immunology·TypeObservational study·DateJun 19, 2024

Monitoring shows chikungunya epidemics can be predicted by means of surveillance

A study in São Paulo state found that chikungunya virus circulated silently for years before causing major epidemics. The researchers monitored residents for four years and discovered a significant rise in seroprevalence from 0.35% to 2.3%. This finding underscores the need for strengthened disease surveillance.

SourceFundação de Amparo à Pesquisa do Estado de São Paulo·JournalPLOS Neglected Tropical Diseases·DateJun 11, 2024

New, modified CRISPR protein can fit inside virus used for gene therapy

Researchers have developed a compact, high-fidelity version of the Cas12a protein, which can be packaged within a non-pathogenic virus for targeted gene editing. The modified protein demonstrates efficient editing activity and has been shown to reduce blood cholesterol levels in mice with high cholesterol.

SourcePLOS·JournalPLOS Biology·TypeExperimental study·DateMay 30, 2024

Bird flu: diverse range of vaccines platforms “crucial” for enhancing human pandemic preparedness

A new review emphasizes the importance of vaccination in preventing avian influenza spread among humans. The study suggests that a diverse range of vaccine platforms, including inactivated and live attenuated vaccines, as well as emerging alternatives like mRNA vaccines, will be crucial for enhancing pandemic preparedness.

SourceTaylor & Francis Group·JournalHuman Vaccines & Immunotherapeutics·TypeLiterature review·DateMay 29, 2024

Finnish Vole fever spreading further south

A new study has discovered that bank voles in southern Sweden carry a virus that can cause hemorrhagic fever in humans, spreading the disease further south than previously known. The virus strain is closely related to strains from Finland and Karelia.

SourceUppsala University·JournalEmerging Infectious Diseases·TypeObservational study·DateMay 28, 2024

Mimicking infection in pregnant mice provokes persistent changes in juvenile brains

Researchers at Harvard University have identified a specific cell type in the mouse embryonic brain that responds to an immune response in the mother, altering gene regulation and persisting in juvenile mice. This study provides new insights into how maternal immune responses might influence brain development in embryos, potentially sh...

SourceThe Company of Biologists·JournalDevelopment·TypeExperimental study·DateMay 22, 2024

Dopamine inhibits the expression of hepatitis b virus surface and e antigens by activating the JAK/STAT pathway and upregulating interferon-stimulated gene 15 expression

A study found that dopamine inhibits the expression of HBV surface and e antigens in HepG2 cells, increasing interferon-stimulated gene 15 expression. The JAK/STAT pathway was also activated, leading to decreased HBV DNA and antigen expression in a mouse model.

SourceXia & He Publishing Inc.·JournalJournal of Clinical and Translational Hepatology·DateMay 14, 2024

First detection of hepatitis E virus from urban Norway rats (Rattus norvegicus) in the Republic of Korea

Researchers in South Korea have detected the first hepatitis E virus from urban Norway rats, raising concerns about potential human transmission. The study found that 4.4% of examined rats carried the virus, which is linked to symptoms like fever, fatigue, and jaundice in humans.

SourceKorea University College of Medicine·JournalJournal of Medical Virology·TypeExperimental study·DateMay 10, 2024

Beneficial effects of traditional Cinese medicine Fuzheng Huayu on the occurrence of hepatocellular carcinoma in patients with compensated chronic hepatitis b cirrhosis receiving entecavir

A multicenter retrospective cohort study found that combining entecavir with Fuzheng Huayu reduced the cumulative incidence of hepatocellular carcinoma in patients with compensated chronic hepatitis B cirrhosis. The antifibrotic property of FZHY may be attributed to its beneficial effects on this population.

SourceXia & He Publishing Inc.·JournalJournal of Clinical and Translational Hepatology·DateApr 30, 2024

How immune cells communicate to fight viruses

Researchers at Universitatsklinikum Bonn have developed a novel technology to identify chemokine-producing cells and sensors, revealing that natural killer cells are the primary producers of Ccl3 during CMV infection. This discovery sheds light on the complex choreography of immune cells in defending against viruses.

SourceUniversitatsklinikum Bonn·JournalJournal of Experimental Medicine·DateApr 25, 2024

Giant viruses infect deadly parasite

Scientists have isolated giant viruses that infect the deadly human parasite Naegleria fowleri, which causes primary amoebic meningoencephalitis. The newly discovered Naegleiaviruses were found in wastewater treatment plants near Vienna and exhibit a unique stargate structure for DNA entry.

SourceUniversity of Vienna·JournalNature Communications·DateApr 24, 2024

A gene mutation associated with a rare neurological disorder and increased susceptibility to viral infections may be treatable with oleic acid

Researchers identified a gene mutation associated with impaired natural killer cell function, leading to increased susceptibility to viral infections in people with a rare genetic condition. Oleic acid supplementation shows promise as a potential therapy for these patients.

SourceUniversity of California - Los Angeles Health Sciences·JournalNature Immunology·TypeExperimental study·DateApr 8, 2024

Wild plants face viral surprise

A recent study published in Phytobiomes Journal found that non-native crop viruses are infecting and harming wild desert plants. Infection rates with the virus CABYV reached as high as 88% in some populations, causing visible impacts on plant growth and root health.

SourceMichigan State University·JournalPhytobiomes Journal·DateMar 28, 2024

Wayne State University researchers uncover potential treatment targets for Zika virus-related eye abnormalities

A groundbreaking study reveals that targeting cholesterol metabolism can mitigate Zika virus-induced ocular pathology, offering promising therapeutic strategies. Researchers identified ABCG1 and SREBP-2 as key players in the pathway, and treatments with LXR agonists or SREBP-2 inhibitors showed promise in animal models.

SourceWayne State University - Office of the Vice President for Research·JournaliScience·TypeExperimental study·DateMar 28, 2024

Duke-NUS research discovery sparks hope: Zika virus vaccine emerges as an unlikely hero in battling brain cancer

A recent study published in the Journal of Translational Medicine discovered that Zika virus vaccine strains can eradicate brain tumour cells while leaving healthy ones intact. The vaccine candidates were found to target rapidly proliferating cancerous cells, making them an ideal option for treating fast-growing brain cancers.

SourceDuke-NUS Medical School·JournalJournal of Translational Medicine·TypeExperimental study·DateMar 8, 2024